Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in Ehrlich solid tumor-Reference-Cited by-同舟云学术

Baicalin; a promising chemopreventive agent, enhances the antitumor effect of 5-FU against breast cancer and inhibits tumor growth and angiogenesis in Ehrlich solid tumor

Published:2022-02 Issue: Volume:146 Page:112599
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Shehatta Nisreen H.,Okda Tarek M.,Omran Gamal A.,Abd-Alhaseeb Mohammad M.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference66 articles.

1. Ameliorative effects of vitamin B17 on the kidney against Ehrlich ascites carcinoma induced renal toxicity in mice;Mutar;Environ. Toxicol.,2020

2. Association between serum soluble Toll‑like receptor 2 and 4 and the risk of breast cancer;El‑Kharashy;Mol. Clin. Oncol.,2021

3. TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells;Wu;Cancer Cell Int.,2017

4. LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression;Luo;Cell Death Dis.,2020

5. Thymoquinone-chemotherapeutic combinations: new regimen to combat cancer and cancer stem cells;El-Far;Naunyn-Schmiedeberg’s Arch. Pharmacol.,2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management;Frontiers in Pharmacology;2024-08-23

2. The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential;Pathology - Research and Practice;2024-08

3. Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations;Bioorganic Chemistry;2024-08

4. Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice;Pharmaceutics;2024-07-13

5. Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights;Drug Development Research;2024-07